Future studies will be required to determine whether the Sema4B pathway is actionable for the improvement of metabolic health, for instance to enhance adipocyte recruitment to mitigate the detrimental metabolic effects associated with obesity or to enhance thermogenesis. This evidence concerns the gene SEMA4B and obesity due to melanocortin 4 receptor deficiency.